Superworth

DBV Technologies market cap DBVT

Share price times shares outstanding: what the whole company sells for, since 2018.

Today, Nov 2, 2026
$569M
Highest close in our data
$1.3B
Apr 2026

DBV Technologies is worth $569M at the close on Nov 2, 2026, at $9.05 a share.

That is up 20% over the last year and up 1618% over five years.

Its highest close in our data was $1.3B in Apr 2026.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$569M$535.9M$1.3B−12%
2025$648.4M$13M$769.8M+5166%
2024$12.3M$9.6M$23.4M−33%
2023$18.4M$14.3M$38.2M−36%
2022$28.8M$13.3M$49.6M+63%
2021$17.6M$17.6M$71.7M−29%
2020$24.6M$13.5M$56.6M−24%
2019$32.6M$15.6M$32.6M+127%
2018$14.4M$14.4M$61.7Mn/a

Against its peers

Companies in Biotechnology nearest DBV Technologies' size, closest first, today.

CompanyMarket cap
DBVTDBV Technologies$569M
MGTXMeiraGTx$895.1M
PLXProtalix BioTherapeutics$206.3M
VCELVericel$2.1B
ADMAAdma Biologics$2.5B
Peer median$1.5B

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on DBV Technologies

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.